Rentokil Initial plc Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before January 27, 2025 to Discuss Your Rights - RTO
Werte in diesem Artikel
NEW YORK, Dec. 19, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rentokil Initial plc (NYSE: RTO).
Shareholders who purchased shares of RTO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
CLASS PERIOD: December 1, 2023 to September 10, 2024
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Rentokil experienced levels of disruption in the early pilots of the Terminix integration; (2) Rentokil experienced significant, ongoing, self-inflicted execution challenges integrating Terminix; (3) the disruption and execution challenges imperiled Rentokil's integration plan for Terminix; (4) Rentokil and Terminix were still two separate businesses that were not yet integrated; (5) Rentokil's failure to integrate Terminix negatively impacted the Company's business and operations, particularly organic revenue growth in North America; and (6) as a result of the above, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
DEADLINE: January 27, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/rentokil-initial-plc-loss-submission-form/?id=117265&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of RTO during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is January 27, 2025. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download multimedia:https://www.prnewswire.com/news-releases/rentokil-initial-plc-sued-for-securities-law-violations--investors-should-contact-the-gross-law-firm-before-january-27-2025-to-discuss-your-rights--rto-302335703.html
SOURCE The Gross Law Firm
Ausgewählte Hebelprodukte auf Rentokil Initial
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Rentokil Initial
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Rentokil Initial PlcShs
Analysen zu Rentokil Initial PlcShs
Datum | Rating | Analyst | |
---|---|---|---|
18.03.2013 | Rentokil Initial verkaufen | Exane-BNP Paribas SA | |
27.02.2013 | Rentokil Initial verkaufen | Exane-BNP Paribas SA | |
28.11.2012 | Rentokil Initial underperform | Exane-BNP Paribas SA | |
09.05.2012 | Rentokil Initial overweight | Morgan Stanley | |
08.11.2011 | Rentokil Initial overweight | Morgan Stanley |
Datum | Rating | Analyst | |
---|---|---|---|
09.05.2012 | Rentokil Initial overweight | Morgan Stanley | |
08.11.2011 | Rentokil Initial overweight | Morgan Stanley | |
09.05.2011 | Rentokil Initial overweight | Morgan Stanley | |
11.01.2011 | Rentokil Initial buy | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Datum | Rating | Analyst | |
---|---|---|---|
18.03.2013 | Rentokil Initial verkaufen | Exane-BNP Paribas SA | |
27.02.2013 | Rentokil Initial verkaufen | Exane-BNP Paribas SA | |
28.11.2012 | Rentokil Initial underperform | Exane-BNP Paribas SA | |
05.04.2005 | Rentokil Initial: Underperform | Goldman Sachs | |
05.04.2005 | Rentokil Initial: Sell | Dresdner Kleinwort Wasserstein |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Rentokil Initial PlcShs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen